Literature DB >> 3732153

Evidence for a specific estradiol binding site on rat pituitary membranes.

D Bression, M Michard, M Le Dafniet, P Pagesy, F Peillon.   

Abstract

Using adenohypophyses from normal female rats, we demonstrate that estradiol binds pituitary membranes to one homogeneous population of sites with high affinity [dissociation constant (Kd) = 0.041 +/- 0.014 nM; n = 6] and low capacity [maximum binding (Bmax) = 13.6 +/- 5.6 fmol/mg protein]. The binding is thermolabile. Association experiments show that the best experimental conditions are an overnight incubation at 0 C. When the amount of proteins is increased more than 0.3 mg/ml of membrane suspension, binding is rapidly nonlinear. The presence of 0.5 M leupeptin does not improve the binding. Extensive washing of the membranes does not decrease the amount of sites, indicating that the binding is not loosely attached to the membranes. Parenthetically, it should be noted that the membrane fraction was devoid of the cytosolic enzyme marker, lactate dehydrogenase. Binding is specific for estrogenic compounds. When 100% specific binding was determined in the presence of 10(-6) M diethylstilbestrol, 17 beta-estradiol, estrone, and estriol displaced total binding by 110, 80, and 75%, respectively. Neither 4-OH-tamoxifen nor dihydrotestosterone, progesterone, or cortisol displaced the binding. Taken together, these data argue in favor of the presence of specific membrane recognition sites for estradiol in the rat pituitary.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3732153     DOI: 10.1210/endo-119-3-1048

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  Estradiol-mediated internalisation of the non-activated estrogen receptor from the goat uterine plasma membrane: identification of the proteins involved.

Authors:  S Sreeja; Raghava Varman Thampan
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

2.  Cell surface expression of the 70-kD component of Ku, a DNA-binding nuclear autoantigen.

Authors:  B S Prabhakar; G P Allaway; J Srinivasappa; A L Notkins
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

3.  Antibodies to the estrogen receptor-alpha modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors.

Authors:  A M Norfleet; C H Clarke; B Gametchu; C S Watson
Journal:  FASEB J       Date:  2000-01       Impact factor: 5.191

4.  Rapid actions of 17beta-oestradiol on a subset of lactotrophs in the rat pituitary.

Authors:  H C Christian; J F Morris
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

5.  Identification of dexamethasone-binding sites on male-rat liver plasma membranes by affinity labelling.

Authors:  G M Howell; C Po; Y A Lefebvre
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

6.  Characterization by photoaffinity labeling of a steroid binding protein in rat liver plasma membrane.

Authors:  I Ibarrola; A Alejandro; A Marino; M J Sancho; J M Macarulla; M Trueba
Journal:  J Membr Biol       Date:  1992-01       Impact factor: 1.843

7.  Mechanisms of 17 beta-oestradiol induced vasodilatation in isolated pressurized rat small arteries.

Authors:  L Shaw; M J Taggart; C Austin
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

8.  Acute, nongenomic actions of the neuroactive gonadal steroid, 3 alpha-hydroxy-4-pregnen-20-one (3 alpha HP), on FSH release in perifused rat anterior pituitary cells.

Authors:  C A Beck; M Wolfe; L D Murphy; J P Wiebe
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

Review 9.  Looking beyond the dogma of genomic steroid action: insights and facts of the 1990s.

Authors:  M Wehling
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

10.  Steroid hormone specifically binds to rat kidney plasma membrane.

Authors:  I Ibarrola; K Ogiza; A Marino; J M Macarulla; M Trueba
Journal:  J Bioenerg Biomembr       Date:  1991-12       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.